Bionpharma Inc. v. Corerx, Inc.
- John Koeltl
- 1:21-cv-10656
- U.S. District Court · Southern District of New York
- 2
In Bionpharma v. CoreRx, Judge Koeltl granted CoreRx’s request to keep specified confidential pricing information sealed.
CoreRx, Bionpharma, and members of the public seeking access to the specified portions of Bionpharma’s proposed findings and conclusions.
What happened
Bionpharma Inc. v. CoreRx, Inc. involved CoreRx’s request to keep portions of Bionpharma’s proposed findings and legal conclusions under seal.
CoreRx said the redacted material contained confidential pricing, costs, revenues, and product-pricing information that could harm it if disclosed to competitors and customers. Bionpharma did not object to the request.
Judge Koeltl granted the application and ordered the identified portions to remain sealed.
The detailed version
- Bionpharma Inc. v. Corerx, Inc. · No. 1:21-cv-10656
- John Koeltl
- Apr. 13, 2023
Background
CoreRx’s counsel asked the court to maintain under seal portions of Bionpharma’s Proposed Findings of Fact and Conclusions of Law that had been redacted from the publicly filed version. The letter identified information concerning CoreRx’s pricing, costs, revenues, and the way it prices pharmaceutical products. CoreRx argued that public disclosure could harm it in dealings with competitors and customers. The letter stated that Bionpharma did not object.
Ruling
The court granted the application and ordered the specified portions of Bionpharma’s proposed findings and conclusions to remain under seal. The opinion does not address the underlying merits of the parties’ dispute.
Read the full 2-page opinion on CourtListener, the free public archive maintained by the Free Law Project.